Page last updated: 2024-10-30

leflunomide and Cancer of Kidney

leflunomide has been researched along with Cancer of Kidney in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salomon, S1
Steinbrüchel, DA1
Nielsen, B1
Lillevang, S1
Kemp, E1

Other Studies

1 other study available for leflunomide and Cancer of Kidney

ArticleYear
Effect of leflunomide, cyclosporine, and splenectomy in two different organ systems of concordant xenotransplantation in rats.
    Transplantation proceedings, 1996, Volume: 28, Issue:2

    Topics: Animals; Combined Modality Therapy; Cricetinae; Cyclosporine; Drug Therapy, Combination; Heart Trans

1996